Stem Cell Transplant
Stem Cell Transplant is a biological therapy with 58 clinical trials. Currently 5 active trials ongoing. Historical success rate of 67.3%.
Success Metrics
Based on 33 completed trials
Phase Distribution
Phase Distribution
16
Early Stage
34
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
63.5%
33 of 52 finished
36.5%
19 ended early
5
trials recruiting
58
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
Clinical Trials (58)
A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
Immune Ablation and Stem Cell Support for Crohn's Disease
High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors
CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies
Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
Autologous Transplant for Multiple Myeloma
Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation
Combined Haploidentical-Cord Blood Transplantation for Adults and Children
Stem Cell Transplant for Hematological Malignancy
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation
Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 58